Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer - Egyptian Knowledge Bank - troweb

368113

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

Article

Assessment of the efficacy and oncological safety of sentinel lymph node biopsy in node-negative breast cancer using methylene blue dye

Article

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Article

Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

Article

SENTINEL LYMPH NODE BIOPSY USING METHYLENE BLUE DYE IN EARLY BREAST CANCER. IS IT TRULY RELIABLE?

Article

Evaluation of the technique of endoscopic axillary sentinel lymph node biopsy in early-stage node-negative breast cancer

Article

Carbon nanoparticles versus patent blue dye for detection of sentinel lymph node in patients with early breast cancer

Article

Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment

Article

Assessment of accuracy of axillary sentinel lymph node biopsy in medially located breast cancer using methylene blue injection technique: our institute experience

Article

SUBAREOLAR VERSUS PERITUMORAL INJECTION OF METHYLENE BLUE FOR SENTINEL LYMPH NODE DETECTION IN CASES OF EARLY BREAST CANCER